These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 2137259

  • 1. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum.
    Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR.
    Science; 1990 Feb 09; 247(4943):715-8. PubMed ID: 2137259
    [Abstract] [Full Text] [Related]

  • 2. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW, Bennink JR.
    Science; 1989 Jun 02; 244(4908):1072-5. PubMed ID: 2471266
    [Abstract] [Full Text] [Related]

  • 3. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
    Lobigs M, Müllbacher A.
    Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):2676-80. PubMed ID: 8464875
    [Abstract] [Full Text] [Related]

  • 4. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X, Momburg F, Liu T, Abdel Motal UM, Jondal M, Hämmerling GJ, Ljunggren HG.
    Eur J Immunol; 1994 Aug 01; 24(8):1863-8. PubMed ID: 8056044
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model.
    Grunhaus A, Cho S, Horwitz MS.
    Virology; 1994 May 01; 200(2):535-46. PubMed ID: 8178441
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG, Biddison WE, Klausner RD.
    Nature; 1990 Jan 04; 343(6253):74-6. PubMed ID: 1967486
    [Abstract] [Full Text] [Related]

  • 10. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D, Marti M, Long EO.
    J Exp Med; 1990 Sep 01; 172(3):947-54. PubMed ID: 2388037
    [Abstract] [Full Text] [Related]

  • 11. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.
    Shen X, Wong SB, Buck CB, Zhang J, Siliciano RF.
    J Immunol; 2002 Oct 15; 169(8):4222-9. PubMed ID: 12370352
    [Abstract] [Full Text] [Related]

  • 12. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R, Kolaitis G, Michaelis C, Tufaro F, Jefferies WA.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Sigal LJ, Crotty S, Andino R, Rock KL.
    Nature; 1999 Mar 04; 398(6722):77-80. PubMed ID: 10078533
    [Abstract] [Full Text] [Related]

  • 14. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L, Ullrich SJ, Appella E, Fuchs S.
    Nature; 1990 Jul 05; 346(6279):63-6. PubMed ID: 2366863
    [Abstract] [Full Text] [Related]

  • 15. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb.
    Zhou X, Glas R, Liu T, Ljunggren HG, Jondal M.
    Eur J Immunol; 1993 Aug 05; 23(8):1802-8. PubMed ID: 8393799
    [Abstract] [Full Text] [Related]

  • 16. High peptide affinity for MHC class I does not correlate with immunodominance.
    Müllbacher A, Lobigs M, Yewdell JW, Bennink JR, Tha Hla R, Blanden RV.
    Scand J Immunol; 1999 Oct 05; 50(4):420-6. PubMed ID: 10520183
    [Abstract] [Full Text] [Related]

  • 17. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation.
    Nuchtern JG, Bonifacino JS, Biddison WE, Klausner RD.
    Nature; 1989 May 18; 339(6221):223-6. PubMed ID: 2785645
    [Abstract] [Full Text] [Related]

  • 18. Antigen presentation: structural themes and functional variations.
    Braciale TJ, Braciale VL.
    Immunol Today; 1991 Apr 18; 12(4):124-9. PubMed ID: 1711855
    [Abstract] [Full Text] [Related]

  • 19. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Raafat N, Sadowski-Cron C, Mengus C, Heberer M, Spagnoli GC, Zajac P.
    Int J Cancer; 2012 Sep 01; 131(5):E659-69. PubMed ID: 22116674
    [Abstract] [Full Text] [Related]

  • 20. Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules.
    Dasgupta A, Hammarlund E, Slifka MK, Früh K.
    J Immunol; 2007 Feb 01; 178(3):1654-61. PubMed ID: 17237415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.